Recent clinical studies have demonstrated promising results for hyperbaric oxygen therapy (HBOT) in treating long COVID symptoms. Researchers at leading medical institutions have found significant improvements in patients suffering from persistent fatigue, brain fog, and respiratory issues.
Study Results:
- 70% of patients reported reduced fatigue after 10 HBOT sessions
- Cognitive function tests showed 35% improvement in memory and concentration
- Inflammatory markers decreased by an average of 45%
- Quality of life scores improved by 50% on average
The mechanism behind HBOT's effectiveness for long COVID involves:
1. Reducing inflammation in brain tissue and blood vessels
2. Promoting neuroplasticity and cognitive recovery
3. Improving mitochondrial function and cellular energy production
4. Enhancing immune system regulation
Longfian's hyperbaric chamber systems are designed to deliver precise oxygen concentrations and pressure levels required for therapeutic applications. Our chambers are used in hospitals and clinics worldwide for various conditions including wound healing, sports recovery, and now increasingly for post-COVID treatment.
As research continues, HBOT may become a standard treatment protocol for long COVID patients who have not responded to conventional therapies.